Overcoming Cambodia's reliance on few trade partners: An analysis by The Asian Vision Institute

PHNOM PENH, Cambodia, March 20, 2020 /PRNewswire/ -- The economy of Cambodia is to suffer the effec...

2020-03-20 07:00 3446

Merck and Pfizer Provide Update on Phase III JAVELIN Head and Neck 100 Study

Not intended for US-, Canada- and UK-based media  DARMSTADT, Germany and NEW YORK, March 13, 2020 /...

2020-03-13 20:00 7891

Merck's New LANEXO™ System to Improve Scientists' Productivity in the Lab

-  First-to-market digital laboratory informatics solution with RFID labels for rapid access to rea...

2020-03-04 03:00 3215

Institute for Real Growth Announces 'IRG 100' Selected Participants for IRG CMO Leadership Program

NEW YORK, Feb. 19, 2020 /PRNewswire/ -- The Institute for Real Growth (IRG) today announced the 'IR...

2020-02-19 09:00 1364

Kemin Offers Immune Support Products Amid Global Health Concerns

DES MOINES, Iowa, Feb. 19, 2020 /PRNewswire/ -- As a global ingredient manufacturer that strives to...

2020-02-19 08:00 2107

Kemin Names Leo Xie-Lei President of Kemin AquaScience™

Xie-Lei will helm the company's newest business unit as its first president transitions into strate...

2020-02-03 09:00 1476

Firmenich Achieves Top EcoVadis Platinum Sustainability Rating, Ranking in the Top 1%

GENEVA, Switzerland, Jan. 29, 2020 /PRNewswire/ -- Firmenich, the world's largest privately-owned P...

2020-01-29 21:00 2238

Joint Action for World Leprosy Day 2020

TOKYO, Jan. 24, 2020 /PRNewswire/ -- Sasakawa Health Foundation has announced the start of its firs...

2020-01-24 10:00 1495

Inovio Selected by CEPI to Develop Vaccine Against New Coronavirus

PLYMOUTH MEETING, Pa., Jan. 24, 2020 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) toda...

2020-01-24 00:26 3712

BAVENCIO Significantly Improved Overall Survival in Patients With Locally Advanced or Metastatic Urothelial Carcinoma

Not intended for US-, Canada- and UK-based media  - At the planned interim analysis, Phase III J...

2020-01-06 20:00 4629

Merck Licenses Foundational CRISPR Integration Technology to Promega

- Gives scientists a new view into natural cell activity, accelerating drug development DARMSTADT,...

2019-12-19 21:00 2237

Squirrel AI Learning Attends the Web Summit to Talk About the Application and Breakthrough of Artificial Intelligence in the Field of Education

LISBON, Portugal, Dec. 17, 2019 /PRNewswire/ -- Web Summit, a global internet-based summit dubbed b...

2019-12-17 15:58 1455

IGU is pleased to issue a new report highlighting how the increased use of natural gas in industry, power generation, heating and transport can significantly reduce air pollution

BARCELONA, Spain, Dec. 11, 2019 /PRNewswire/ -- Urban Air Quality remains a major threat to human h...

2019-12-11 18:00 885

Firmenich Signs UN Global Compact Action Platform for Decent Work in Global Supply Chains

GENEVA, Dec. 11, 2019 /PRNewswire/ -- On Human Rights Day, Firmenich, the world's largest priva...

2019-12-11 02:12 1371

Legendary Advocate for Freedom, Democracy and Human Rights Natan Sharansky Awarded 2020 Genesis Prize

Joins Michael Bloomberg and Justice Ruth Bader Ginsburg as Recipient of Prestigious Jewish Award J...

2019-12-10 12:15 865

Art Edition "Art 19 - Box One" to Benefit Amnesty International

BERLIN, Nov. 25, 2019 /PRNewswire/ -- Art 19, in association with Amnesty International, announces ...

2019-11-25 07:05 1015

Avon partners with WAGGGS to help more women and girls to #SpeakOutListenUp on gender-based violence

LONDON, Nov. 19, 2019 /PRNewswire/ -- Avon Products Inc. (NYSE: AVP): Avon and the Avon Foundation ...

2019-11-19 20:30 2571

Merck and Pfizer Provide Update on Phase III JAVELIN Gastric 100 Trial

Not intended for US, Canada and UK-based media  DARMSTADT, Germany, and NEW YORK, Nov. 8, 2019 /PRN...

2019-11-08 21:00 5854

MOM's Household Services Scheme sees promising success as millennial home ownership rise

SINGAPORE, Nov. 5, 2019 /PRNewswire/ -- Helpling , Singapore's leading...

2019-11-05 12:51 1587

European Commission Approves BAVENCIO® (avelumab) Plus Axitinib Combination for First-Line Treatment of Patients With Advanced Renal Cell Carcinoma

Not intended for US, Canada and UK-based media  -- EU approval based on JAVELIN Renal 101 trial re...

2019-10-29 02:00 1700
1 ... 1011121314